Price Chart

Key Stats

Customize
Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.75% 0.52% 28.08M 46232.00
Dividend Yield Turnover Ratio 1 Year Fund Level Flows Max Drawdown (All)
0.00% 54.09% 667808.6 Upgrade

Basic Info

Investment Strategy
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Innovation Labs Cannabis Index. The fund will invest at least 80% of its total assets in the component securities of the index. It will also invest, under normal circumstances, at least 80% of its net assets, plus borrowings for investment purposes, in exchange listed common stock (or corresponding American Depositary Receipts ("ADRs") of Cannabis Companies. The index is a proprietary, rules-based index designed to track the performance of a portfolio of Cannabis Companies. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Small Cap/Value
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Miscellaneous Sector
Category Index Morningstar US Market TR USD
Global Category Name Equity Miscellaneous
YCharts Categorization Other
YCharts Benchmark S&P 500 Total Return (^SPXTR)
Prospectus Objective Specialty - Unaligned
Fund Owner Firm Name Innovation Shares
Prospectus Benchmark Index
Innovation Labs Cannabis TR USD 100.0%
Broad Asset Class Benchmark Index
^MSWNTR 100.0%
Manager Tenure
Michael Obuchowski 3.32 yrs

Net Fund Flows Versus Category

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: 50
667808.6
-759.84M Category Low
750.75M Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
As of October 31, 2022

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of November 25, 2022. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
--
--
--
--
--
4.24%
-31.67%
-62.76%
-0.87%
7.51%
22.40%
-8.71%
27.67%
15.90%
21.82%
-15.07%
3.35%
11.01%
14.33%
-13.34%
25.56%
-1.13%
28.26%
-21.68%
--
13.15%
39.37%
-21.77%
-28.52%
-11.63%
-21.66%
-47.27%
--
--
--
--
--
47.01%
-20.54%
-60.32%
--
--
--
--
--
31.97%
-19.02%
-49.92%
As of November 25, 2022.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (11-25-22) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of November 25, 2022

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of November 25, 2022

Asset Allocation

As of November 25, 2022.
Type % Net % Long % Short
Cash 0.00% Upgrade Upgrade
Stock 100.00% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.00% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
GrowGeneration Corp 11.02% 5.84 0.17%
AFC Gamma Inc Ordinary Shares 7.55% 17.01 0.95%
OrganiGram Holdings Inc 7.38% 1.31 -2.96%
Canopy Growth Corp 7.31% 4.81 1.69%
Cronos Group Inc 7.21% 4.18 -0.95%
Village Farms International Inc 7.06% 2.11 1.93%
Tilray Brands Inc 6.98% 3.85 5.19%
The Scotts Miracle Gro Co A 6.22% 55.55 -1.82%
Waters Corp 5.72% 338.03 0.31%
High Tide Inc 5.58% 2.51 0.80%

Basic Info

Investment Strategy
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Innovation Labs Cannabis Index. The fund will invest at least 80% of its total assets in the component securities of the index. It will also invest, under normal circumstances, at least 80% of its net assets, plus borrowings for investment purposes, in exchange listed common stock (or corresponding American Depositary Receipts ("ADRs") of Cannabis Companies. The index is a proprietary, rules-based index designed to track the performance of a portfolio of Cannabis Companies. The fund is non-diversified.
General
Security Type Exchange-Traded Fund
Equity Style Small Cap/Value
Fixed Income Style --
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Miscellaneous Sector
Category Index Morningstar US Market TR USD
Global Category Name Equity Miscellaneous
YCharts Categorization Other
YCharts Benchmark S&P 500 Total Return (^SPXTR)
Prospectus Objective Specialty - Unaligned
Fund Owner Firm Name Innovation Shares
Prospectus Benchmark Index
Innovation Labs Cannabis TR USD 100.0%
Broad Asset Class Benchmark Index
^MSWNTR 100.0%
Manager Tenure
Michael Obuchowski 3.32 yrs

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (11-25-22) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of November 25, 2022

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of November 25, 2022

Fund Details

Key Dates
Inception Date 7/9/2019
Last Annual Report Date 2/28/2022
Last Prospectus Date 7/1/2022
Attributes
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No

Top Portfolio Holders

0 of 0